Literature DB >> 26609470

Muc1 promotes migration and lung metastasis of melanoma cells.

Xiaoli Wang1, Hongwen Lan2, Jun Li2, Yushu Su2, Lijun Xu2.   

Abstract

Early stages of melanoma can be successfully treated by surgical resection of the tumor, but there is still no effective treatment once it is progressed to metastatic phases. Although growing family of both melanoma metastasis promoting and metastasis suppressor genes have been reported be related to metastasis, the molecular mechanisms governing melanoma metastatic cascade are still not completely understood. Therefore, defining the molecules that govern melanoma metastasis may aid the development of more effective therapeutic strategies for combating melanoma. In the present study, we found that muc1 is involved in the metastasis of melanoma cells and demonstrated that muc1 disruption impairs melanoma cells migration and metastasis. The requirement of muc1 in the migration of melanoma cells was further confirmed by gene silencing in vitro. In corresponding to this result, over-expression of muc1 significantly promoted the migratory of melanoma cells. Moreover, down-regulation of muc1 expression strikingly inhibits melanoma cellular metastasis in vivo. Finally, we found that muc1 promotes melanoma migration through the protein kinase B (Akt) signaling pathway. To conclude, our findings suggest a novel mechanism underlying the metastasis of melanoma cells which might serve as a new intervention target for the treatment of melanoma.

Entities:  

Keywords:  Akt; Melanoma; metastasis; muc1

Year:  2015        PMID: 26609470      PMCID: PMC4633892     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  32 in total

1.  LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a.

Authors:  Jiaqian Liang; Xin Li; Yirong Li; Jianjun Wei; Garrett Daniels; Xuelin Zhong; Jinhua Wang; Karen Sfanos; Jonathan Melamed; Jun Zhao; Peng Lee
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways.

Authors:  Solange Tréhoux; Bélinda Duchêne; Nicolas Jonckheere; Isabelle Van Seuningen
Journal:  Biochem Biophys Res Commun       Date:  2014-12-13       Impact factor: 3.575

3.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

4.  RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells.

Authors:  Zhiqi Song; Jingrong Lin; Zhe Sun; Jing Ni; Yang Sha
Journal:  J Dermatol Sci       Date:  2015-04-09       Impact factor: 4.563

5.  Epithelial MUC1 promotes cell migration, reduces apoptosis and affects levels of mucosal modulators during acetylsalicylic acid (aspirin)-induced gastropathy.

Authors:  Debashish Banerjee; Harvey Robert Fernandez; Pradeep Bhatu Patil; Pushpa Premaratne; Marianne Quiding-Järbrink; Sara Katarina Lindén
Journal:  Biochem J       Date:  2015-02-01       Impact factor: 3.857

6.  The MUC1 mucin regulates the tumorigenic properties of human esophageal adenocarcinomatous cells.

Authors:  Caroline Gronnier; Emilie Bruyère; Fatima Lahdaoui; Nicolas Jonckheere; Michaël Perrais; Emmanuelle Leteurtre; Guillaume Piessen; Christophe Mariette; Isabelle Van Seuningen
Journal:  Biochim Biophys Acta       Date:  2014-07-06

7.  Expression of human full-length MUC1 inhibits the proliferation and migration of a B16 mouse melanoma cell line.

Authors:  Fengli Wang; Qiongshu Li; Weihua Ni; Fang Fang; Xiaxia Sun; Fei Xie; Juan Wang; Fang Wang; Sujun Gao; Guixiang Tai
Journal:  Oncol Rep       Date:  2013-04-30       Impact factor: 3.906

Review 8.  MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.

Authors:  D W Kufe
Journal:  Oncogene       Date:  2012-05-14       Impact factor: 9.867

9.  Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.

Authors:  Pierluigi Gasparini; Matteo Fassan; Luciano Cascione; Gulnur Guler; Serdar Balci; Cigdem Irkkan; Carolyn Paisie; Francesca Lovat; Carl Morrison; Jianying Zhang; Aldo Scarpa; Carlo M Croce; Charles L Shapiro; Kay Huebner
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

Review 10.  The melanocyte lineage in development and disease.

Authors:  Richard L Mort; Ian J Jackson; E Elizabeth Patton
Journal:  Development       Date:  2015-02-15       Impact factor: 6.868

View more
  7 in total

1.  Glutathione-s-transferase A 4 (GSTA4) suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting AKT pathway.

Authors:  Chang Jun Liu; Jin Hui Yang; Fei Zhou Huang; Wan Pin Nie; Chu Ping Liu; Xian Hai Mao; Xin Min Yin; Xian Bo Shen; Chuang Peng; Mei Fu Chen; Bo Jiang; Xun Yang Liu; Jin Shu Wu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma.

Authors:  Tingting Ren; Lili Zhu; Mingliang Cheng
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

3.  Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma.

Authors:  Long Jiang; Bhairavi Tolani; Che-Chung Yeh; Yanying Fan; Joseph A Reza; Andrew E Horvai; Endi Xia; Johannes R Kratz; David M Jablons; Michael J Mann
Journal:  Cancer Manag Res       Date:  2019-09-09       Impact factor: 3.989

4.  Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells.

Authors:  Anna Piotrowska; Fernando Pereira Beserra; Justyna Marta Wierzbicka; Joanna Irena Nowak; Michał Aleksander Żmijewski
Journal:  Front Oncol       Date:  2021-12-24       Impact factor: 6.244

Review 5.  Cell Adhesion Molecules in Plasticity and Metastasis.

Authors:  Jessica A Smart; Julia E Oleksak; Edward J Hartsough
Journal:  Mol Cancer Res       Date:  2020-10-01       Impact factor: 6.333

6.  A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression.

Authors:  Elliot C Woods; FuiBoon Kai; J Matthew Barnes; Kayvon Pedram; Michael W Pickup; Michael J Hollander; Valerie M Weaver; Carolyn R Bertozzi
Journal:  Elife       Date:  2017-12-21       Impact factor: 8.140

Review 7.  From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past.

Authors:  Mahdi Abdoli Shadbad; Khalil Hajiasgharzadeh; Afshin Derakhshani; Nicola Silvestris; Amir Baghbanzadeh; Vito Racanelli; Behzad Baradaran
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.